Here’s what you should know:
1. Takeda will begin the sale process in October, in an attempt to sell the property by the end of the year.
2. The company believes the headquarters and properties adjacent to the building will sell for about $542.39 million ($60 billion yen.)
3. Takeda will lease space in the existing buildings and continue operating out of them after the sale.
4. Takeda is planning on acquiring Shire for nearly $63 billion ($7 trillion yen.) The acquisition will make Takeda the most indebted drugmaker in the world.
5. In advance of the acquisition, Takeda has begun divesting other nonessential properties.
More articles on supply chain:
7 things for ASC leaders to know for Thursday — July 5, 2018
Providers from 35 states charged in healthcare fraud crackdown: Here’s the breakdown
The Joint Commission revises TJR advanced certification requirements: 2 new rules for ASCs
